Mickiene Gitana, Dalgėdienė Indrė, Zvirblis Gintautas, Dapkunas Zilvinas, Plikusiene Ieva, Buzavaite-Verteliene Ernesta, Balevičius Zigmas, Rukšėnaitė Audronė, Pleckaityte Milda
Institute of Biotechnology, Vilnius University, Vilnius, Lithuania.
Profarma UAB, Vilnius, Lithuania.
PeerJ. 2020 Aug 21;8:e9788. doi: 10.7717/peerj.9788. eCollection 2020.
Stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF) are well-characterized vital hematopoietic growth factors that regulate hematopoiesis. G-CSF and SCF synergistically exhibit a stimulatory effect on hematopoietic progenitors. The combination of G-CSF and SCF has been used for mobilization of peripheral blood progenitor cells in cancer and non-cancerous conditions. To overcome challenges connected with the administration of two cytokines, we developed two fusion proteins composed of human SCF and human G-CSF interspaced by an alpha-helix-forming peptide linker.
The recombinant proteins SCF-Lα-GCSF and GCSF-Lα-SCF were purified in three steps using an ion-exchange and mixed-mode chromatography. The purity and quantity of the proteins after each stage of purification was assessed using RP-HPLC, SDS-PAGE, and the Bradford assays. Purified proteins were identified using high-performance liquid chromatography/electrospray ionization mass spectrometry (HPLC/ESI-MS) and the Western blot analyses. The molecular weight was determined by size exclusion HPLC (SE-HPLC). The activity of heterodimers was assessed using cell proliferation assays in vitro. The capacity of recombinant fusion proteins to stimulate the increase of the absolute neutrophil count in rats was determined in vivo. The binding kinetics of the proteins to immobilized G-CSF and SCF receptors was measured using total internal reflection ellipsometry and evaluated by a standard Langmuir kinetics model.
The novel SCF-Lα-GCSF and GCSF-Lα-SCF proteins were synthesized in . The purity of the heterodimers reached >90% as determined by RP-HPLC. The identity of the proteins was confirmed using the Western blot and HPLC/ESI-MS assays. An array of multimeric forms, non-covalently associated dimers or trimers were detected in the protein preparations by SE-HPLC. Each protein induced a dose-dependent proliferative response on the cell lines. At equimolar concentration, the heterodimers retain 70-140% of the SCF monomer activity ( ≤ 0.01) in promoting the M-07e cells proliferation. The G-CSF moiety in GCSF-Lα-SCF retained 15% ( ≤ 0.0001) and in SCF-Lα-GCSF retained 34% ( ≤ 0.01) of the monomeric G-CSF activity in stimulating the growth of G-NFS-60 cells. The obtained results were in good agreement with the binding data of each moiety in the fusion proteins to their respective receptors. The increase in the absolute neutrophil count in rats caused by the SCF-Lα-GCSF protein corresponded to the increase induced by a mixture of SCF and G-CSF.
干细胞因子(SCF)和粒细胞集落刺激因子(G-CSF)是已被充分表征的重要造血生长因子,可调节造血作用。G-CSF和SCF协同对造血祖细胞表现出刺激作用。G-CSF和SCF的组合已用于在癌症和非癌症情况下动员外周血祖细胞。为了克服与两种细胞因子给药相关的挑战,我们开发了两种由人SCF和人G-CSF组成的融合蛋白,中间间隔一个形成α-螺旋的肽接头。
重组蛋白SCF-Lα-GCSF和GCSF-Lα-SCF通过离子交换和混合模式色谱三步纯化。使用反相高效液相色谱(RP-HPLC)、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和Bradford测定法评估纯化各阶段后蛋白质的纯度和数量。使用高效液相色谱/电喷雾电离质谱(HPLC/ESI-MS)和蛋白质印迹分析鉴定纯化的蛋白质。通过尺寸排阻高效液相色谱(SE-HPLC)测定分子量。使用体外细胞增殖试验评估异二聚体的活性。在体内测定重组融合蛋白刺激大鼠绝对中性粒细胞计数增加的能力。使用全内反射椭圆偏振法测量蛋白质与固定化G-CSF和SCF受体的结合动力学,并通过标准朗缪尔动力学模型进行评估。
新型SCF-Lα-GCSF和GCSF-Lα-SCF蛋白在……中合成。通过RP-HPLC测定,异二聚体的纯度达到>90%。使用蛋白质印迹和HPLC/ESI-MS测定法确认了蛋白质的身份。通过SE-HPLC在蛋白质制剂中检测到一系列多聚体形式、非共价结合的二聚体或三聚体。每种蛋白质对细胞系均诱导剂量依赖性增殖反应。在等摩尔浓度下,异二聚体在促进M-07e细胞增殖方面保留了SCF单体活性的70-140%(P≤0.01)。GCSF-Lα-SCF中的G-CSF部分在刺激G-NFS-60细胞生长方面保留了单体G-CSF活性的15%(P≤0.0001),在SCF-Lα-GCSF中保留了34%(P≤0.01)。所得结果与融合蛋白中各部分与其各自受体的结合数据高度一致。SCF-Lα-GCSF蛋白引起的大鼠绝对中性粒细胞计数增加与SCF和G-CSF混合物诱导的增加相当。